Company News

FDA Grants 510(k) Clearance to Prontosan

B. Braun's wound management gel available OTC.

Author Image

By: TOM BRANNA

Editor

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for B. Braun’s Prontosan Wound Management Gel for OTC use. Prontosan Wound Management Gel with PHMB (Polyhexanide), which was rolled out in 2009,was initially used in healthcare settings for cleaning wounds as well as moistening and lubricating absorbent wound dressings. “Effective wound care management nolonger needs to be limited to within healthcare facility walls,” said Mike Kelly, director of marketing, ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters